MYGN Financial Facts
See Full Income StatementDeferred taxes: 7.51M
Total stockholders' equity: 664.93M
See Full Balance Sheet
Earnings History for Myriad Genetics Inc. (MYGN)
|
Expand Research on MYGN
| Next EPS Date | 5/2/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/10  |
 |
Q111 | $0.24 | $0.23 | +$0.01 | N/A | N/A | N/A / N/A |  |
+59.3% | Details |
| 5/3/11 |
|
Q311 | $0.31 | $0.25 | +$0.06 | $102.4M | $98.11M | N/A / N/A | |
+47.1% | Details |
| 1/27/11 |
|
Q211 | $0.26 | $0.26 | $0.00 | $100.4M | $98.84M | N/A / N/A | |
+40.4% | Details |
| 11/1/11 |
|
Q112 | $0.29 | $0.28 | +$0.01 | $110.5M | $106.49M | N/A / N/A | = | +54.4% | Details |
| 8/9/11 |
|
Q411 | $0.30 | $0.29 | +$0.01 | $107.4M | $104.43M | N/A / N/A | = | +66.1% | Details |
| 1/31/12 |
|
Q212 | $0.33 | $0.31 | +$0.02 | $122.8M | $115.28M | N/A / N/A | = | +32.7% | Details |
| 11/5/12 |
|
Q113 | $0.36 | $0.32 | +$0.04 | $133.44M | $129.43M | N/A / N/A | = | +16.9% | Details |
| 5/1/12 |
|
Q112 | $0.34 | $0.32 | +$0.02 | $129.8M | $119.2M | N/A / N/A | = | +20.6% | Details |
